Germline (G)BRCA1/2 Mutations (M) and Hematological Toxicities in Patients (PTS) with Triple Negative Breast Cancer (TNBC) Treated with Neoadjuvant Chemotherapy (NACT) - Furlanetto, Jenny; Moebus, Volker; Schneeweiss, Andreas; Rhiem, Kerstin; Tesch, Hans; Blohmer, Jens-Uwe; Luebbe, Kristina; Untch, Michael; Salat, Christoph; Huober, Jens; Klare, Peter; Schmutzler, Rita; et al. (ONCOLOGY RESEARCH AND TREATMENT, 2020)
CRIS-Team WoS Importer:2020-03-20